Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience. Cancer. 2013 Oct 15; 119(20):3687-95.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
CTLA-4 Antigen
Female
Follow-Up Studies
Humans
Ipilimumab
Male
Melanoma
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Prognosis
Retrospective Studies
Skin Neoplasms
Survival Rate
Universities
Uveal Neoplasms